Modulation of the Disordered Conformational Ensembles of the p53 Transactivation Domain by Cancer-Associated Mutations
Fig 6
Residue helicity profiles for the wild-type p53-TAD and five cancer mutants, derived from the last 80-ns segments of the RE-GA simulations.
Estimated uncertainties are similar for all profiles and only shown for the wild-type for clarity.